Cancer stands as a serious malady, posing substantial risks to human well‐being and
survival. This underscores the paramount necessity to explore and investigate novel …

Non-small cell lung cancer is the leading cause of cancer related mortality worldwide, and
lung adenocarcinoma (LUAD) is one of the most common subtypes. The role of N6 …

Lung cancer is an uncontrolled and abnormal mass of growing cells with the highest
mortality rate in the world. Progressive lung cancer shows a robust resistance to cancer …

Background Lung adenocarcinoma (LUAD) is the most common pathological type of lung
cancer. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been …

Cancer is the second leading cause of death worldwide, and despite the effort of standard
treatments, the search for new tools against this disease is necessary. Importantly, it is …

The peritoneal cavity offers an attractive administration route for challenging-to-treat
diseases, such as peritoneal carcinomatosis, post-surgical adhesions, and peritoneal …

Sixteen new 2-substituted quinazolines were synthesized using a straightforward
methodology starting from 2-methoxybezoic acid or 3-methoxy-2-naphthoic acid. The anti …

Aims: This study was aimed to formulate erlotinib (ERL)-loaded transferosomal gel (ERL@
TG) intended for topical application for the treatment of ductal carcinoma in situ. Materials & …

Aim: This study aimed to improve the delivery and therapeutic potential of gefitinib (GTB)
against breast cancer by preparing GTB-loaded, nanostructured lipid carriers (GTB-NLCs) …

The therapeutic effect of gefitinib on colorectal cancer (CRC) is unclear, but it has been
reported that stromal cells in the tumor microenvironment may have an impact on drug …